Surveillance for hepatocellular carcinoma: It is time to move forward.
作者信息
Kim Bo Hyun, Cho Yuri, Park Joong-Won
机构信息
Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
出版信息
Clin Mol Hepatol. 2022 Oct;28(4):810-813. doi: 10.3350/cmh.2022.0257. Epub 2022 Sep 6.
Abstract
摘要
相似文献
1
Surveillance for hepatocellular carcinoma: It is time to move forward.
Clin Mol Hepatol. 2022 Oct;28(4):810-813. doi: 10.3350/cmh.2022.0257. Epub 2022 Sep 6.
2
Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India.
Trop Gastroenterol. 2008 Oct-Dec;29(4):183-6.
3
Surveillance for hepatocellular carcinoma...a hotly debated issue.
Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):255-64.
4
Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality.
Ultraschall Med. 2013 Oct;34(5):483-4. doi: 10.1055/s-0033-1346750.
5
Towards a New Horizon for Individualized Surveillance Tools in Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol. 2022 Jan;20(1):25-27. doi: 10.1016/j.cgh.2021.04.041. Epub 2021 Apr 30.
6
Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis.
Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):651-3. doi: 10.1586/egh.12.59.
7
[Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Rev Prat. 2013 Feb;63(2):222-5.
8
Serological surveillance for hepatocellular carcinoma: time to quit.
J Hepatol. 2010 Apr;52(4):614-5. doi: 10.1016/j.jhep.2009.11.026. Epub 2010 Jan 14.
9
Surveillance for hepatocellular carcinoma: how can we do better?
Am J Med Sci. 2013 Oct;346(4):308-13. doi: 10.1097/MAJ.0b013e31828318ff.
10
Screening for hepatocellular carcinoma in cirrhosis.
J Hepatol. 2003 Dec;39(6):1076-84. doi: 10.1016/s0168-8278(03)00349-0.
引用本文的文献
1
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery.
Front Immunol. 2025 Apr 22;16:1582203. doi: 10.3389/fimmu.2025.1582203. eCollection 2025.
2
Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area.
Cancers (Basel). 2023 Dec 28;16(1):150. doi: 10.3390/cancers16010150.
3
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap.
Clin Mol Hepatol. 2023 Apr;29(2):349-351. doi: 10.3350/cmh.2023.0082. Epub 2023 Mar 20.
4
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Clin Mol Hepatol. 2023 Apr;29(2):332-334. doi: 10.3350/cmh.2023.0080. Epub 2023 Mar 16.
5
The prime time for management of hepatocellular carcinoma in Hong Kong.
Clin Mol Hepatol. 2023 Apr;29(2):345-348. doi: 10.3350/cmh.2023.0094. Epub 2023 Mar 9.
6
Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease".
Clin Mol Hepatol. 2023 Jan;29(1):182-184. doi: 10.3350/cmh.2022.0411. Epub 2022 Nov 22.
本文引用的文献
1
Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry.
J Liver Cancer. 2020 Sep;20(2):135-147. doi: 10.17998/jlc.20.2.135. Epub 2020 Sep 30.
2
Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry.
J Liver Cancer. 2021 Mar;21(1):58-68. doi: 10.17998/jlc.21.1.58. Epub 2021 Mar 31.
3
Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry.
J Liver Cancer. 2020 Mar;20(1):41-52. doi: 10.17998/jlc.20.1.41. Epub 2020 Mar 31.
4
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
Clin Mol Hepatol. 2022 Oct;28(4):851-863. doi: 10.3350/cmh.2022.0037. Epub 2022 Jun 3.
5
Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts.
PLoS One. 2022 Mar 24;17(3):e0265668. doi: 10.1371/journal.pone.0265668. eCollection 2022.
6
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023. Epub 2022 Feb 6.
7
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
Hepatology. 2022 Jul;76(1):139-154. doi: 10.1002/hep.32341. Epub 2022 Feb 7.
8
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection.
Clin Mol Hepatol. 2022 Jul;28(3):351-361. doi: 10.3350/cmh.2021.0281. Epub 2021 Nov 26.
9
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
J Hepatol. 2022 Feb;76(2):311-318. doi: 10.1016/j.jhep.2021.09.025. Epub 2021 Oct 2.
10
Hepatocellular carcinoma statistics in South Korea.
Clin Mol Hepatol. 2021 Jul;27(3):512-514. doi: 10.3350/cmh.2021.0171. Epub 2021 Jun 21.
Zotero 插件